Modulating Kupffer cell activation is a potential therapeutic strategy for treating liver diseases. Anti-inflammatory drugs, antioxidants, and specific inhibitors of signaling pathways involved in Kupffer cell activation are being explored to reduce liver inflammation and fibrosis. Understanding the molecular mechanisms of Kupffer cell activation is crucial for developing these therapeutic interventions.
